These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
458 related items for PubMed ID: 7533182
21. Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen. Zaremba S, Barzaga E, Zhu M, Soares N, Tsang KY, Schlom J. Cancer Res; 1997 Oct 15; 57(20):4570-7. PubMed ID: 9377571 [Abstract] [Full Text] [Related]
22. Clearance of Chlamydia pneumoniae infection in H-2 class I human leucocyte antigen-A2.1 monochain transgenic mice. Tammiruusu A, Haveri A, Pascolo S, Lahesmaa R, Stevanovic S, Rammensee HG, Sarvas M, Puolakkainen M, Vuola JM. Scand J Immunol; 2005 Aug 15; 62(2):131-9. PubMed ID: 16101819 [Abstract] [Full Text] [Related]
23. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. Cerny A, McHutchison JG, Pasquinelli C, Brown ME, Brothers MA, Grabscheid B, Fowler P, Houghton M, Chisari FV. J Clin Invest; 1995 Feb 15; 95(2):521-30. PubMed ID: 7860734 [Abstract] [Full Text] [Related]
24. Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients. Jaramillo A, Narayanan K, Campbell LG, Benshoff ND, Lybarger L, Hansen TH, Fleming TP, Dietz JR, Mohanakumar T. Breast Cancer Res Treat; 2004 Nov 15; 88(1):29-41. PubMed ID: 15538043 [Abstract] [Full Text] [Related]
27. Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacements. Huarte E, Sarobe P, Lu J, Casares N, Lasarte JJ, Dotor J, Ruiz M, Prieto J, Celis E, Borrás-Cuesta F. Clin Cancer Res; 2002 Jul 15; 8(7):2336-44. PubMed ID: 12114438 [Abstract] [Full Text] [Related]
28. A panel of unique HLA-A2 mutant molecules define epitopes recognized by HLA-A2-specific antibodies and cytotoxic T lymphocytes. Hogan KT, Clayberger C, Bernhard EJ, Walk SF, Ridge JP, Parham P, Krensky AM, Engelhard VH. J Immunol; 1989 Mar 15; 142(6):2097-104. PubMed ID: 2466083 [Abstract] [Full Text] [Related]
29. Mice expressing the E7 oncogene of HPV16 in epithelium show central tolerance, and evidence of peripheral anergising tolerance, to E7-encoded cytotoxic T-lymphocyte epitopes. Doan T, Chambers M, Street M, Fernando GJ, Herd K, Lambert P, Tindle R. Virology; 1998 May 10; 244(2):352-64. PubMed ID: 9601506 [Abstract] [Full Text] [Related]
31. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2. Yamazaki K, Spruill G, Rhoderick J, Spielman J, Savaraj N, Podack ER. Cancer Res; 1999 Sep 15; 59(18):4642-50. PubMed ID: 10493519 [Abstract] [Full Text] [Related]
32. Comparison of cytotoxic T lymphocyte responses induced by peptide or DNA immunization: implications on immunogenicity and immunodominance. Vitiello A, Sette A, Yuan L, Farness P, Southwood S, Sidney J, Chesnut RW, Grey HM, Livingston B. Eur J Immunol; 1997 Mar 15; 27(3):671-8. PubMed ID: 9079808 [Abstract] [Full Text] [Related]
33. Diversity and dominance among TCR recognizing HLA-A2.1+ influenza matrix peptide in human MHC class I transgenic mice. Man S, Ridge JP, Engelhard VH. J Immunol; 1994 Nov 15; 153(10):4458-67. PubMed ID: 7963521 [Abstract] [Full Text] [Related]
35. Specificity of peptide binding by the HLA-A2.1 molecule. Shimojo N, Maloy WL, Anderson RW, Biddison WE, Coligan JE. J Immunol; 1989 Nov 01; 143(9):2939-47. PubMed ID: 2553813 [Abstract] [Full Text] [Related]
36. Immunogenic variation between multiple HLA-A*0201-restricted, Hepatitis C Virus-derived epitopes for cytotoxic T lymphocytes. Ohno S, Moriya O, Yoshimoto T, Hayashi H, Akatsuka T, Matsui M. Viral Immunol; 2006 Nov 01; 19(3):458-67. PubMed ID: 16987064 [Abstract] [Full Text] [Related]
37. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Gotch F, Rothbard J, Howland K, Townsend A, McMichael A. Nature; 2006 Nov 01; 326(6116):881-2. PubMed ID: 2437457 [Abstract] [Full Text] [Related]